Inmune Bio, Inc. 10-Q

Item 5. Other Information Not applicable. Item 6. Exhibits No. Description 10.1 Amendment to Exclusive License Agreement 31.1 Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer* 31.2 Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer* 32.1 Section 1350 Certification of Chief Executive Officer** 32.2 Section 1350 Certification of Chief Financial Officer** 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema 101.CAL XBRL Taxonomy Extension Calculation Linkbase 101.DEF XBRL Taxonomy Extension Definition Linkbase 101.LAB XBRL Taxonomy Extension Label Linkbase 101.PRE XBRL Taxonomy Extension Presentation Linkbase 28 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INmune Bio Inc. Date: November 5, 2020 By: /s/ Raymond J. Tesi Raymond J. Tesi Chief Executive Officer (Principal Executive Officer) Date: November 5, 2020 By: /s/ David J. Moss David J. Moss Chief Financial Officer, Treasurer, Secretary (Principal Financial and Accounting Officer) 29